ABS Laboratories has opened a new, state-of-the-art laboratory in York, which analyses drugs, including nicotine and other related compounds, in saliva, urine and plasma for organizations conducting preclinical and clinical trials, as well as other development initiatives, to combat diseases.
Acquired by ACM Global Laboratories, one of the largest global independent laboratories in the industry, ABS has recently located from Welwyn Garden City near London, to Hospital Fields Road opposite ACM's European Headquarters. ABS has plans to expand the team in York in 2020, joining ACM's 120+ York-based team.
The company has invested more than £1M in the 7,500 sq. ft. laboratory, which includes support from a £175,000 Let's Grow North & East Yorkshire grant, to transform the disused warehouse into a world-leading facility. ABS Laboratories has also invested in major software and hardware upgrades including a new Liquid Chromatograph Tandem Mass Spectrometer (LC-MS/MS). The new equipment will provide sensitive assays for the development of new drugs, advanced quantitative smoking and nicotine replacement therapy analysis including government funded smoking cessation programmes in England and Scotland.
ABS Laboratories was founded 24 years ago by scientists Drs. Colin Feyerabend and Mira Doig, who have been instrumental in the company's growth and in managing its move to York.
Dr. Mira Doig, laboratory manager and technical director, ABS Laboratories said: "ABS' growth and evolution throughout the decades has brought new ways of working and understanding of the science of drug development to this area of the industry. Commitment, passion and quality in science has been critical to success behind our work. Today we are here to celebrate another leap forward with brilliant new facilities, leading-edge technology and equipment, and a well-rounded team. Being in York with ACM will bring greater collaboration and more opportunities for the business."
ABS was purchased by ACM Global Laboratories in 2018 as part of a strategic growth initiative, which sees it looking to expand its collection of domestic and international laboratories focused on bioanalytical, toxicology and central lab testing.
Speaking at the grand opening of the new laboratory, Brian Wright, president, ACM Global Laboratories, said: "ABS Laboratories' expansion and relocation is an important initiative for both ABS and ACM, with significant investment to provide state-of-the-art clinical trial testing and central laboratory services. Collaboration with the scientific community here in York and abroad will advance our global footprint so we can continue to help generations to come."
Simon Middleton, business growth manager at Make It York said: "We are delighted to support the team at ACM and ABS Laboratories. The grant has brought inward investment into the City of York and good-quality new jobs at the same time. Businesses of this nature are vitally important to the future economic prosperity of the city and we are pleased to have played a small part in achieving a successful outcome."
ABS Laboratories is a GLP and GCP MHRA accredited facility and has experience in supporting pharmaceutical companies, academic institutions and government agencies around the world, complementing ACM's growing portfolio.
Rochester Regional Health is an integrated health services organization serving the people of Western New York, the Finger Lakes and beyond. The system includes five hospitals; primary and specialty practices, rehabilitation centers, ambulatory campuses and immediate care facilities; innovative senior services, facilities and independent housing; a wide range of behavioral health services; and Rochester Regional Health Laboratories and ACM Global Laboratories, a global leader in patient and clinical trials. Rochester Regional Health is the region’s second largest employer. Learn more at RochesterRegional.org.
ACM Global Laboratories, an affiliate of Rochester Regional Health, is one of the largest global independent central labs in the industry. ACM is certified by the College of American Pathologists (CAP) and the Substance Abuse and Mental Health Services Administration (SAMHSA). The company delivers high-quality laboratory testing and diagnostic lab services in support of both clinical trials research, toxicology and individual patient care. ACM provides a powerful combination of operational excellence, scientific expertise and unsurpassed global service to customers in more than 65 countries. ACM performs more than 30 million laboratory tests each year—spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology and more. For more information, visit ACMGlobalLab.com or call +1-866-405-0400.